PARENT SESSION
9:00 AM to 11:00 AM
Monday, April 22, 2002
NAHS Symposium 11
NAHS Thermal Ablation Therapy
Room: Nevada 1-2
Chair: Diederich, Chris²²Radiation Oncology Dept., San Francsico, CA, Co-Chair: Sherar, Michael³³Dept. of Medical Biophysics, Toronto, Ontario, Canada
Speakers: Sherar, Michael³; Shinohara, Katsuto⁵; Hynynen, Kullervo⁶; Goldberg, Nahum⁷³Dept. of Medical Biophysics, Toronto, Ontario, Canada⁵Univ. California, San Francisco, CA⁶Dept. of Radiology, Boston, MA⁷Beth Israel Deaconess Medical Center, Boston, MA

(S11-) Thermal Ablation Therapy.

Diederich, Chris^*,1, Sherar, Michael², ¹ Department of Radiation Oncology, San Francisco, CA² University of Toronto, Princess Margaret Hospital, Toronto, ON

ABSTRACT-
Percutaneous, intracavitary, and extracorporeal image-guided ablative therapies using thermal energy sources such as RF current, microwave, high intensity ultrasound, cryotherapy, and laser have received much recent attention as minimally-invasive strategies for the treatment of cancer and benign disease. Potential benefits of these techniques include the ability to ablate targets in non-surgical candidates, reduced morbidity as compared to surgery or radiation therapy, and the potential to perform the procedure on an outpatient basis. These procedures are now being performed in sites such as breast, liver, brain, prostate, uterus, kidney, lung, soft tissue, etc. The speakers in this Symposium will present various clinical approaches to delivering high-temperature thermal therapy to some of the aforementioned sites, including discussion of both engineering principles associated with the specified heating technology and summaries of recent clinical results.

KEYWORDS: ablation, coagulation, high-temperature, thermal therapy